AbbVie to Present at Citi's 2024 Global Healthcare Conference
AbbVie to Present at Citi's 2024 Global Healthcare Conference
NORTH CHICAGO, Ill., Nov. 25, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in Citi's 2024 Global Healthcare Conference on Tuesday, December 3, 2024. Scott T. Reents, executive vice president, chief financial officer, Jeffrey R. Stewart, executive vice president, chief commercial officer and Roopal Thakkar, M.D., executive vice president, Research & Development and chief scientific officer, will present at 9:15 a.m. Central time.
伊利诺伊州北芝加哥,2024年11月25日/ PRNewswire/ - 艾伯维公司(纽交所:ABBV) 将参加2024年12月3日星期二Citi全球医疗会议。 首席财务官Scott T. Reents,首席商务官Jeffrey R. Stewart 和首席科学官及研发执行副总裁Roopal Thakkar女士将于美国中部时间上午9:15参会。
A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.
演示的现场录音网络广播将通过艾伯维公司的投资者关系网站investors.abbvie.com 访问。 当天晚些时候将提供演讲节目的存档版本。
About AbbVie
关于艾伯维公司
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at . Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.
艾伯维公司的使命是发现和提供能够解决当今严重健康问题并解决明天的医疗挑战的创新药物和解决方案。我们致力于在几个重要治疗领域 – 免疫学、肿瘤学、神经科学和眼科领域及我们的爱尔兰雅品牌组合中产生显著影响。有关艾伯维公司的更多信息,请访问我们的网站 。在LinkedIn上关注@abbvie,Instagram, Facebook, Instagram, X (曾用名Twitter),,和 YouTube。
SOURCE AbbVie
消息来源 艾伯维
译文内容由第三方软件翻译。